Oral etoposide as a single agent in childhood and young adult cancer in England: Still a poorly evaluated palliative treatment

Author:

Fraser Jess12,Wills Lorna1,Fardus‐Reid Fahmina1,Irvine Lucy1,Elliss‐Brookes Lucy1ORCID,Fern Lorna3ORCID,Cameron Alison L.4,Pritchard‐Jones Kathy5ORCID,Feltbower Richard G.6,Shelton Jon2,Stiller Charles1,McCabe Martin G.17ORCID

Affiliation:

1. National Cancer Registration and Analysis Service (NCRAS) Public Health England London UK

2. Cancer Research UK London UK

3. Cancer Division University College London Hospitals NHS Foundation Trust London UK

4. Bristol Haematology Oncology Centre University Hospitals Bristol NHS Foundation Trust Bristol UK

5. University College London Great Ormond Street Institute of Child Health London UK

6. Leeds Institute for Data Analytics, School of Medicine University of Leeds Leeds UK

7. Division of Cancer Sciences, Faculty of Biology, Medicine and Health University of Manchester Manchester UK

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference33 articles.

1. Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials

2. Children's Cancer and Leukaemia Group.CCLG Clinical Guidelines.CCLG;2020.

3. IrvineL StillerC.Childhood Cancer Statistics England Annual Report 2018.Public Health England;2018.

4. Response of recurrent medulloblastoma to low-dose oral etoposide.

5. Recurrent brainstem gliomas treated with oral VP-16

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3